SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
HYPR

Hyperfine, Inc. (NASDAQ:HYPR)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$0.55+$0.02 (+4.27%)
 
Market cap
$49.7M
Insider Score
Health Score
Analyst consensus
Listed since
Jan 28, 2021
Market Cap$49.73M-48.0%
Revenue (ttm)$19.06M+80.0%
Net Income-$29.81M+25.6%
EPS-$0.30+41.8%
Shares Out90.99M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,239,541
Open$0.53
Previous Close$0.52
Day's Range$0.49 - $0.55
52-Week Range$0.49 - $1.94
Beta1.50
AnalystsBuy
Price Target$1.80(+229.37%)
Earnings DateMar 17, 2027

About HYPR

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

Address
351 New Whitfield Street, Guilford, CT, 06437, US
Market Cap
50 million
Employees
102
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$93.46K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $1.80 (+229.4%)

1 firm rating HYPR in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Weak
From HYPR’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+4.27%
5 Days
-12.56%
1 Month
-26.77%
6 Months
-63.57%
1 Year
-47.95%

$HYPR stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in HYPR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by HYPR's directors and management

Net Shares Purchased by Insiders−50k−25k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

HYPR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

HYPR Revenue by Segment

$5.96MTotal
Device$5.24M87.97%
Service$717.00K12.03%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New HYPR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to HYPR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in HYPR

VTIVanguard Morningstar Total Stock Market ETF$1.32M
IWMiShares Russell 2000 ETF$891.42K
VXFVanguard Extended Market ETF$674.32K
IWOiShares Russell 2000 Growth ETF$390.73K
VTWOVanguard Russell 2000 ETF$326.09K
IWCiShares Micro-Cap ETF$124.60K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from HYPR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Q3 2026 results featured record revenue with 73% growth; company presenting at major healthcare conference signals momentum.

Recent Insider Activity

Buys
0
Sells
8
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-51.0 since Aug 26
0255075100Aug 26 — Insider Score 51.0Aug 27 — Insider Score 51.0Aug 28 — Insider Score 51.0Aug 29 — Insider Score 51.0Aug 30 — Insider Score 51.0Aug 31 — Insider Score 51.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 40.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 26Sep 14Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.05%

Weight is the stock’s share of each fund’s holdings.